291 TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK Profile

✍ Scribed by Ohkubo, S.; Muraoka, H.; Hashimoto, A.; Ito, S.; Ito, K.; Shibata, Y.; Kanoh, A.; Kitade, M.; Yonekura, K.; Utsugi, T.

• Book ID: 121968598
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 62 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(12)72089-0